Abbott’s $23B Exact Sciences bet: bold or risky?

Abbott's $23 billion acquisition of Exact Sciences positions the company to become a major player in cancer diagnostics. Experts think the deal makes strategic sense, as it offers higher margins and a broader commercial scale — but questions remain about long-term growth amid rising competition and the challenges of integrating a patient-focused, tech-heavy business.

MedCity News will be observing Thanksgiving this week and will resume publishing the newsletter on December 1.

Editor's Pick

Top Story Abbott's $23B Bet on Exact Sciences: Bold Move or Risky Gamble? Abbott's $23 billion acquisition of Exact Sciences positions the company to become a major player in cancer diagnostics. Experts think the deal makes strategic sense, as it offers higher margins and a broader commercial scale — but questions remain about long-term growth amid rising competition and the challenges of integrating a patient-focused, tech-heavy business. Sponsored Shop and Compare: Online Health Insurance Options in California Presented by Health for California Here are some of the top online health insurance options worth exploring — each designed to simplify coverage decisions while meeting California's high standards for accessibility and compliance. Learn More

Featured News

FamilyWell Health Lands $8M to Grow Women's Mental Health Support FamilyWell's financing was led by New Markets Venture Partners and included participation from .406 Ventures, GreyMatter Capital, The Alix Foundation, The Donna Fund and The Lee Foundation. The Opportunity being Missed in UK Healthcare Buyouts Following Brexit, the funding infrastructure for new buyout funds in the UK has broken down. These new managers are now struggling to find anchor investors and offer an opportunity to the private sector to step in and secure attractive returns. Orthopedics Cracked the Code on Wait Times: Here's How They Did It The answer may lie in the specialty's proactive adoption of digital tools and its commitment to patient-first strategies that reduce friction, modernize scheduling, and streamline access.

Video   Video: Looking for smarter health guidance? Carolyn Jasik from Verily talks about their telemedicine app linking users to licensed doctors and Violet, an AI that answers your health questions using your own medical records. Watch the interview to see how Verily is changing health access.

Resources

Compare Costs for Top Telemedicine Software Platforms Explore real pricing data and see what telemedicine tools offer at different budget tiers—from entry-level options to enterprise-ready systems. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe